These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 24398441)

  • 1. High-dose fibrinogen versus a clinically recommended dose of fresh frozen plasma for reversal of dilutional coagulopathy in an in vitro model of severe hemodilution.
    Rosenthal C; Rau J; Volk T; Sander M; Ziemer S; Von Heymann C
    Minerva Anestesiol; 2014 Aug; 80(8):894-903. PubMed ID: 24398441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution.
    Haas T; Fries D; Velik-Salchner C; Reif C; Klingler A; Innerhofer P
    Anesth Analg; 2008 May; 106(5):1360-5, table of contents. PubMed ID: 18420845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%.
    De Lorenzo C; Calatzis A; Welsch U; Heindl B
    Anesth Analg; 2006 Apr; 102(4):1194-200. PubMed ID: 16551923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin-induced coagulopathy is less severe and more effectively reversed with fibrinogen concentrate than is synthetic colloid-induced coagulopathy.
    Winstedt D; Hanna J; Schött U
    Scand J Clin Lab Invest; 2013 Mar; 73(2):161-9. PubMed ID: 23368782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro.
    Schlimp CJ; Cadamuro J; Solomon C; Redl H; Schöchl H
    Blood Transfus; 2013 Oct; 11(4):510-7. PubMed ID: 23245725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of fibrinogen-, factor VIII- and XIII-mediated clot propagation in gelatin haemodilution.
    Schramko AA; Kuitunen AH; Suojaranta-Ylinen RT; Niemi TT
    Acta Anaesthesiol Scand; 2009 Jul; 53(6):731-5. PubMed ID: 19239406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen and FXIII dose response effects on albumin-induced coagulopathy.
    Hanna J; Winstedt D; Schött U
    Scand J Clin Lab Invest; 2013 Oct; 73(7):553-62. PubMed ID: 24004348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dilutional coagulopathy, an underestimated problem?].
    Fries D; Streif W; Haas T; Kühbacher G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Dec; 39(12):745-50. PubMed ID: 15605299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model.
    Fries D; Innerhofer P; Reif C; Streif W; Klingler A; Schobersberger W; Velik-Salchner C; Friesenecker B
    Anesth Analg; 2006 Feb; 102(2):347-51. PubMed ID: 16428520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of in vitro hemodilution and fibrinogen concentrate substitution on thromboelastometry analysis in patients qualified for liver transplantation - preliminary results.
    Nicińska B; Pluta J; Kosieradzki M; Lągiewska B; Wasiak D; Lazowski T; Chmura A; Trzebicki J
    Transplant Proc; 2014 Oct; 46(8):2758-61. PubMed ID: 25380911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration.
    Mittermayr M; Streif W; Haas T; Fries D; Velik-Salchner C; Klingler A; Oswald E; Bach C; Schnapka-Koepf M; Innerhofer P
    Anesth Analg; 2007 Oct; 105(4):905-17, table of contents. PubMed ID: 17898365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative dilutional coagulopathy treated with fresh frozen plasma and fibrinogen concentrate: a prospective randomized intervention trial.
    Lancé MD; Ninivaggi M; Schols SE; Feijge MA; Oehrl SK; Kuiper GJ; Nikiforou M; Marcus MA; Hamulyak K; van Pampus EC; ten Cate H; Heemskerk JW
    Vox Sang; 2012 Jul; 103(1):25-34. PubMed ID: 22211833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
    Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
    Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the in vitro effects of saline, hypertonic hydroxyethyl starch, hypertonic saline, and two forms of hydroxyethyl starch on whole blood coagulation and platelet function in dogs.
    Wurlod VA; Howard J; Francey T; Schweighauser A; Adamik KN
    J Vet Emerg Crit Care (San Antonio); 2015; 25(4):474-87. PubMed ID: 26037241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profound effects of cardiopulmonary bypass priming solutions on the fibrin part of clot formation: an ex vivo evaluation using rotation thromboelastometry.
    Brinkman AC; Romijn JW; van Barneveld LJ; Greuters S; Veerhoek D; Vonk AB; Boer C
    J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):422-6. PubMed ID: 20056447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is dilutional coagulopathy induced by different colloids reversible by replacement of fibrinogen and factor XIII concentrates?
    Kind SL; Spahn-Nett GH; Emmert MY; Eismon J; Seifert B; Spahn DR; Theusinger OM
    Anesth Analg; 2013 Nov; 117(5):1063-71. PubMed ID: 24029856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated fibrinogen, von Willebrand factor, and Factor VIII confer resistance to dilutional coagulopathy and activated protein C in normal pregnant women.
    Tanaka KA; Bharadwaj S; Hasan S; Judd M; Abuelkasem E; Henderson RA; Chow JH; Williams B; Mazzeffi MA; Crimmins SD; Malinow AM
    Br J Anaesth; 2019 Jun; 122(6):751-759. PubMed ID: 30916034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prohemostatic Activity of Factor X in Combination With Activated Factor VII in Dilutional Coagulopathy.
    Takeshita S; Ogawa S; Nakayama Y; Mukai N; Nakajima Y; Mizobe T; Sawa T; Tanaka KA
    Anesth Analg; 2019 Aug; 129(2):339-345. PubMed ID: 30320649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between standard laboratory and functional tests of coagulation in dilutional coagulopathy: an in vitro study.
    Krzych LJ; Czempik PF
    J Physiol Pharmacol; 2017 Aug; 68(4):637-645. PubMed ID: 29151081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free oscillation rheometry monitoring of haemodilution and hypothermia and correction with fibrinogen and factor XIII concentrates.
    Winstedt D; Tynngård N; Olanders K; Schött U
    Scand J Trauma Resusc Emerg Med; 2013 Mar; 21():20. PubMed ID: 23517637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.